
Chapter 83 HEAD TRAUMA 585
prophylaxis with diphenylhydantoin or levetiracetam is indicated particularly for penetrating
injuries and depressed skull fractures. It is crucial to avoid hypoxia as well because head-
injured patients who experience hypoxia (pO
2
, 60 mm Hg) also have a twofold increase in
mortality. Consequently, early and careful airway management and ventilation are essential.
Coagulopathies should be corrected with fresh frozen plasma, and platelet transfusion
should be considered in patients who have recently taken aspirin or other antiplatelet
drugs.
n
Hyperventilation. Carbon dioxide is one of the main determinants of cerebrovascular tone.
High levels produce cerebral vasodilation; low levels cause vasoconstriction.
Hyperventilation to a PCO
2
level of 25 mm Hg decreases blood flow to the brain by 50%,
which decreases the vascular compartment of the brain and may “buy some time” for
definitive surgical interventions. When blood flow to the brain decreases, delivery of oxygen
and glucose also decreases, resulting in ischemic injury and worse edema. The optimal
level of hypocarbia is uncertain at present, but most clinicians recommend moderate short-
term hyperventilation, with a PCO
2
level no less than 30 to 35 mm Hg as the goal in
patients with evidence of herniation. To accomplish this degree of hypocarbia, it is
necessary to intubate the patient with rapid-sequence intubation and mechanically ventilate
with settings determined by arterial blood gases to maintain the PCO
2
between 30 and
35 mm Hg. The indication for implementing hyperventilation is increased ICP resulting in
clinical signs of focal neurologic deficit (i.e., herniation). Hyperventilation is not used
prophylactically but is reserved for patients with elevated ICP and rapid clinical
deterioration.
n
Diuresis. The use of an osmotic diuretic, such as mannitol, 0.5 to 1.0 g/kg intravenously
over 15 minutes, or a loop diuretic, such as furosemide, 0.5 to 1.0 mg/kg intravenously,
is effective in reducing brain edema. Infusion of mannitol creates an osmotic gradient
between the intravascular space and the extracellular fluid, drawing fluid from the
extracellular fluid and reducing brain water content and ICP. Mannitol is filtered by
the kidneys, producing systemic dehydration. Clinical experience and animal studies
seem to support the concomitant administration of osmotic diuretics and volume
resuscitation in patients with hypovolemic shock.
n
Hypertonic saline. Various concentrations of hypertonic saline ranging from 3% to 23%
have been used to simultaneously decrease brain edema, maintain cerebral perfusion
pressure, and restore systemic volume. It has been shown to be at least as effective as
mannitol in treating elevated ICP. Patients receiving hypertonic saline will develop
significant hypernatremia and hyperosmolarity. Unless serum sodium exceeds 160 mEq/L,
these abnormalities should be allowed to correct themselves gradually over a period of
several days.
n
Ventriculostomy. Although generally an intensive care unit (ICU) technique, removal of CSF
through a ventriculostomy is occasionally implemented in the ED and is perhaps the most
effective way of rapidly lowering ICP.
n
Barbiturates. Conscious patients who are paralyzed for intubation also must be sedated.
A short-acting barbiturate such as thiopental is the ideal agent for this purpose because it
lowers ICP, prevents seizures, and decreases cerebral metabolism. Such agents cannot be
used in a hypotensive patient, however. In these cases, a reversible agent, such as
morphine, 0.1 mg/kg; lorazepam, 0.01 mg/kg; or midazolam, 1 mg/kg/h, is preferred
because adverse effects on blood pressure and cardiac output can be reversed by specific
antagonists. Etomidate, 0.2 mg/kg, is a short-acting agent that decreases ICP without
adversely affecting cardiac output, cerebral perfusion pressure, and systemic blood
pressure and can be used for sedation, although suppression of adrenal function is a
known complication. Fentanyl, 3 to 5 mcg/kg, causes a slight increase in ICP and is not the
preferred agent for sedation of a head-injured patient.
n
Therapeutic hypothermia. Reducing a patient’s body temperature to 32°C to 33°C for 24 to
48 hours has shown some benefit in preserving neurological function in cardiac arrest
survivors and it was hoped that it would show the same benefits in brain-injured patients.